AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Article Link
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article

PCN-Fe(III)-PTX nanoparticles for MRI guided high efficiency chemo-photodynamic therapy in pancreatic cancer through alleviating tumor hypoxia

Tao Zhang1,§Zhenqi Jiang2,3,§Libin Chen4,§Chunshu Pan2Shan Sun2Chuang Liu2Zihou Li2Wenzhi Ren2,5( )Aiguo Wu2( )Pintong Huang1( )
Department of Ultrasound, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China
Cixi Institute of Biomedical Engineering, CAS Key Laboratory of Magnetic Materials and Devices, & Key Laboratory of Additive Manufacturing Materials of Zhejiang Province, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo 315201, China
University of Chinese Academy of Sciences, Beijing 100049, China
Department of Ultrasound, Ningbo First Hospital, Ningbo 315010, China
Key Laboratory of Diagnosis and Treatment of Digestive System Tumors of Zhejiang Province, Ningbo 315016, China

§ Tao Zhang, Zhenqi Jiang, and Libin Chen contributed equally to this work.

Show Author Information

Graphical Abstract

Abstract

As nanomedicine-based clinical strategies have continued to develop, the possibility of combining chemotherapy and singlet oxygen-dependent photodynamic therapy (PDT) to treat pancreatic cancer (PaC) has emerged as a viable therapeutic modality. The efficacy of such an approach, however, is likely to be constrained by the mechanisms of drug release and tumor oxygen levels. In the present study, we developed an Fe(III)-complexed porous coordination network (PCN) which we then used to encapsulate PTX (PCN-Fe(III)-PTX) nanoparticles (NPs) in order to treat PaC via a combination of chemotherapy and PDT. The resultant NPs were able to release drug in response to both laser irradiation and pH changes to promote drug accumulation within tumors. Furthermore, through a Fe(III)-based Fenton-like reaction these NPs were able to convert H2O2 in the tumor site to O2, thereby regulating local hypoxic conditions and enhancing the efficacy of PDT approaches. Also these NPs were suitable for use as a T1-magnetic resonance imaging (MRI) weighted contrast agent, making them viable for monitoring therapeutic efficacy upon treatment. Our results in both cell line and animal models of PaC suggest that these NPs represent an ideal agent for mediating effective MRI-guided chemotherapy-PDT, giving them great promise for the clinical treatment of PaC.

Electronic Supplementary Material

Download File(s)
12274_2019_2610_MOESM1_ESM.pdf (2.4 MB)

References

[1]
Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R. L.; Torre, L. A.; Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2016, 68, 394-424.
[2]
Kamisawa, T.; Wood, L. D.; Itoi, T.; Takaori, K. Pancreatic cancer. Lancet 2016, 388, 73-85.
[3]
Witkowski, E. R.; Smith, J. K.; Tseng, J. F. Outcomes following resection of pancreatic cancer. J. Surg. Oncol. 2013, 107, 97-103.
[4]
Von Hoff, D. D.; Ervin, T.; Arena, F. P.; Chiorean, E. G.; Infante, J.; Moore, M.; Seay, T.; Tjulandin, S. A.; Ma, W. W.; Saleh, M. N. et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N. Engl. J. Med. 2013, 369, 1691-1703.
[5]
Gelderblom, H.; Verweij, J.; Nooter, K.; Sparreboom, A. Cremophor EL: The drawbacks and advantages of vehicle selection for drug formulation. Eur. J. Cancer 2001, 37, 1590-1598.
[6]
Zhang, F. W.; Zhang, S. Y.; Pollack, S. F.; Li, R. C.; Gonzalez, A. M.; Fan, J. W.; Zou, J.; Leininger, S. E.; Pavía-Sanders, A.; Johnson, R. et al. Improving paclitaxel delivery: In vitro and in vivo characterization of PEGylated polyphosphoester-based nanocarriers. J. Am. Chem. Soc. 2015, 137, 2056-2066.
[7]
Feng, Q. H.; Zhang, W. X.; Yang, X. M.; Li, Y. Z.; Hao, Y. W.; Zhang, H. L.; Hou, L.; Zhang, Z. Z. pH/ultrasound dual-responsive gas generator for ultrasound imaging-guided therapeutic inertial cavitation and sonodynamic therapy. Adv. Healthc. Mater.. 2018, 7, 1700957.
[8]
Chen, W. H.; Luo, G. F.; Vázquez-González, M.; Cazelles, R.; Sohn, Y. S.; Nechushtai, R.; Mandel, Y.; Willner, I. Glucose-responsive metal-organic-framework nanoparticles act as “smart” sense-and-treat carriers. ACS Nano 2018, 12, 7538-7545.
[9]
Bansal, A.; Zhang, Y. Photocontrolled nanoparticle delivery systems for biomedical applications. Acc. Chem. Res. 2014, 47, 3052-3060.
[10]
Lee, H.; Han, J.; Shin, H.; Han, H.; Na, K.; Kim, H. Combination of chemotherapy and photodynamic therapy for cancer treatment with sonoporation effects. J. Control. Release 2018, 283, 190-199.
[11]
Jiang, Z. Q.; Wang, Y. J.; Sun, L.; Yuan, B.; Tian, Y. C.; Xiang, L. C.; Li, Y. Y.; Li, Y.; Li, J.; Wu, A. G. Dual ATP and pH responsive ZIF-90 nanosystem with favorable biocompatibility and facile post-modification improves therapeutic outcomes of triple negative breast cancer in vivo. Biomaterials 2019, 197, 41-50.
[12]
Jiang, Z. Q.; Yuan, B.; Qiu, N. X.; Wang, Y. J.; Sun, L.; Wei, Z. N.; Li, Y. Y.; Zheng, J. J.; Jin, Y. H.; Li, Y. et al. Manganese-zeolitic imidazolate frameworks-90 with high blood circulation stability for MRI-guided tumor therapy. Nano-Micro Lett. 2019, 11, 61.
[13]
Spring, B. Q.; Rizvi, I.; Xu, N.; Hasan, T. The role of photodynamic therapy in overcoming cancer drug resistance. Photochem. Photobiol. Sci. 2015, 14, 1476-1491.
[14]
Zhao, Y. Y.; Wei, C. F.; Chen, X.; Liu, J. W.; Yu, Q. Q.; Liu, Y. N.; Liu, J. Drug delivery system based on near-infrared light-responsive molybdenum disulfide nanosheets controls the high-efficiency release of dexamethasone to inhibit inflammation and treat osteoarthritis. ACS Appl. Mater. Interfaces 2019, 11, 11587-11601.
[15]
Bown, S. G.; Rogowska, A. Z.; Whitelaw, D. E.; Lees, W. R.; Lovat, L. B.; Ripley, P.; Jones, L.; Wyld, P.; Gillams, A.; Hatfield, A. W. R. Photodynamic therapy for cancer of the pancreas. Gut 2002, 50, 549-557.
[16]
Hu, D. H.; Chen, Z. W.; Sheng, Z. H.; Gao, D. Y.; Yan, F.; Ma, T.; Zheng, H. R.; Hong, M. A catalase-loaded hierarchical zeolite as an implantable nanocapsule for ultrasound-guided oxygen self-sufficient photodynamic therapy against pancreatic cancer. Nanoscale 2018, 10, 17283-17292.
[17]
Xu, R. Y.; Wang, Y. F.; Duan, X. P.; Lu, K. D.; Micheroni, D.; Hu, A. G.; Lin, W. B. Nanoscale metal-organic frameworks for ratiometric oxygen sensing in live cells. J. Am. Chem. Soc. 2016, 138, 2158-2161.
[18]
Yang, G. B.; Xu, L. G.; Chao, Y.; Xu, J.; Sun, X. Q.; Wu, Y. F.; Peng, R.; Liu, Z. Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses. Nat. Commun. 2017, 8, 902.
[19]
Bristow, R. G.; Hill, R. P. Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat. Rev. Cancer 2008, 8, 180-192.
[20]
Wang, D. D.; Wu, H. H.; Lim, W. Q.; Phua, S. Z. F.; Xu, P. P.; Chen, Q. W.; Guo, Z.; Zhao, Y. L. A mesoporous nanoenzyme derived from metal-organic frameworks with endogenous oxygen generation to alleviate tumor hypoxia for significantly enhanced photodynamic therapy. Adv. Mater. 2019, 31, 1901893.
[21]
Tang, J. Q.; Zhou, H. G.; Hou, X. Y.; Wang, L. M.; Li, Y. X.; Pang, Y. Y.; Chen, C. Y.; Jiang, G.; Liu, Y. Q. Enhanced anti-tumor efficacy of temozolomide-loaded carboxylated poly(amido-amine) combined with photothermal/photodynamic therapy for melanoma treatment. Cancer Lett. 2018, 423, 16-26.
[22]
You, Q.; Sun, Q.; Wang, J. P.; Tan, X. X.; Pang, X. J.; Liu, L.; Yu, M.; Tan, F. P.; Li, N. A single-light triggered and dual-imaging guided multifunctional platform for combined photothermal and photodynamic therapy based on TD-controlled and ICG-loaded CuS@mSiO2. Nanoscale 2017, 9, 3784-3796.
[23]
Cheng, Y. H.; Cheng, H.; Jiang, C. X.; Qiu, X. F.; Wang, K. K.; Huan, W.; Yuan, A. H.; Wu, J. H.; Hu, Y. Q. Perfluorocarbon nanoparticles enhance reactive oxygen levels and tumour growth inhibition in photodynamic therapy. Nat. Commun. 2015, 6, 8785.
[24]
Liu, L. H.; Zhang, Y. H.; Qiu, W. X.; Zhang, L.; Gao, F.; Li, B.; Xu, L.; Fan, J. X.; Li, Z. H.; Zhang, X. Z. Dual-stage light amplified photodynamic therapy against hypoxic tumor based on an O2 self-sufficient nanoplatform. Small 2017, 13, 1701621.
[25]
McEwan, C.; Owen, J.; Stride, E.; Fowley, C.; Nesbitt, H.; Cochrane, D.; Coussios, C. C.; Borden, M.; Nomikou, N.; McHale, A. P. et al. Oxygen carrying microbubbles for enhanced sonodynamic therapy of hypoxic tumours. J. Control. Release 2015, 203, 51-56.
[26]
Halliwell, B.; Clement, M. V.; Long, L. H. Hydrogen peroxide in the human body. FEBS Lett. 2000, 486, 10-13.
[27]
Valko, M.; Izakovic, M.; Mazur, M.; Rhodes, C. J.; Telser, J. Role of oxygen radicals in DNA damage and cancer incidence. Mol. Cell. Biochem. 2004, 266, 37-56.
[28]
Ma, Z. F.; Zhang, M. C.; Jia, X. D.; Bai, J.; Ruan, Y. D.; Wang, C.; Sun, X. P.; Jiang, X. E. FeIII-doped two-dimensional C3N4 nanofusiform: A new O2-evolving and mitochondria-targeting photodynamic agent for MRI and enhanced antitumor therapy. Small 2016, 12, 5477-5487.
[29]
Zheng, D. W.; Li, B.; Li, C. X.; Fan, J. X.; Lei, Q.; Li, C.; Xu, Z. S.; Zhang, X. Z. Carbon-dot-decorated carbon nitride nanoparticles for enhanced photodynamic therapy against hypoxic tumor via water splitting. ACS Nano 2016, 10, 8715-8722.
[30]
Pinto, S. M. A.; Calvete, M. J. F.; Ghica, M. E.; Soler, S.; Gallardo, I.; Pallier, A.; Laranjo, M. B.; Cardoso, A. M. S.; Castro, M. M. C. A.; Brett, C. M. A. et al. A biocompatible redox MRI probe based on a Mn(II)/Mn(III) porphyrin. Dalton Trans. 2019, 48, 3249-3262.
[31]
Shen, Z. Y.; Song, J. B.; Yung, B. C.; Zhou, Z. J.; Wu, A. G.; Chen, X. Y. Emerging strategies of cancer therapy based on ferroptosis. Adv. Mater. 2018, 30, 1704007.
[32]
Lan, G. X.; Ni, K. Y.; Xu, Z. W.; Veroneau, S. S.; Song, Y.; Lin, W. B. Nanoscale metal-organic framework overcomes hypoxia for photodynamic therapy primed cancer immunotherapy. J. Am. Chem. Soc. 2018, 140, 5670-5673.
[33]
Wang, Y. J.; Wang, C.; Gong, C. Y.; Wang, Y. J.; Guo, G.; Luo, F.; Qian, Z. Y. Polysorbate 80 coated poly (ε-caprolactone)-poly (ethylene glycol)-poly (ε-caprolactone) micelles for paclitaxel delivery. Int. J. Pharm. 2012, 434, 1-8.
[34]
Garvie, L. A. J.; Buseck, P. R. Ratios of ferrous to ferric iron from nanometre-sized areas in minerals. Nature 1998, 396, 667-670.
[35]
Liu, C.; Luo, L. J.; Zeng, L. Y.; Xing, J.; Xia, Y. Z.; Sun, S.; Zhang, L. Y.; Yu, Z.; Yao, J. L.; Yu, Z. S. et al. Porous gold nanoshells on functional NH2-MOFs: Facile synthesis and designable platforms for cancer multiple therapy. Small 2018, 14, 1801851.
[36]
Sukhorukov, G. B.; Antipov, A. A.; Voigt, A.; Donath, E.; Möhwald, H. pH-controlled macromolecule encapsulation in and release from polyelectrolyte multilayer nanocapsules. Macromol. Rapid Commun. 2001, 22, 44-46.
[37]
Park, J.; Jiang, Q.; Feng, D. W.; Mao, L. Q.; Zhou, H. C. Size-controlled synthesis of porphyrinic metal-organic framework and functionalization for targeted photodynamic therapy. J. Am. Chem. Soc. 2016, 138, 3518-3525.
[38]
Fan, L.; Zhao, S. S.; Jin, X.; Zhang, Y. S.; Song, C. J.; Wu, H. Synergistic chemo-photodynamic therapy by “big & small combo nanoparticles” sequential release system. Nanomed.: Nanotechnol., Biol. Med. 2018, 14, 109-121.
Nano Research
Pages 273-281
Cite this article:
Zhang T, Jiang Z, Chen L, et al. PCN-Fe(III)-PTX nanoparticles for MRI guided high efficiency chemo-photodynamic therapy in pancreatic cancer through alleviating tumor hypoxia. Nano Research, 2020, 13(1): 273-281. https://doi.org/10.1007/s12274-019-2610-6
Topics:

946

Views

58

Crossref

N/A

Web of Science

62

Scopus

7

CSCD

Altmetrics

Received: 19 October 2019
Revised: 11 December 2019
Accepted: 15 December 2019
Published: 02 January 2020
© Tsinghua University Press and Springer-Verlag GmbH Germany, part of Springer Nature 2019
Return